What this study is
This study is being done at Duke Health and includes adult men who have been treated for localized prostate cancer. The goal is to see if it is feasible and acceptable to offer sex therapy by telehealth after prostate cancer treatment.
All participants receive pelvic floor physical therapy and education about penile rehabilitation, including use of a vacuum erection device. Participants are randomly assigned to one of two groups. One group receives pelvic floor physical therapy plus telehealth sex therapy, with about ten sessions over six months. The other group receives pelvic floor physical therapy alone.
Participants complete questionnaires about urinary and sexual health at the start of the study and over the next two years. Short interviews are also done at 6 and 12 months. Medicines for erectile function are prescribed as part of usual clinical care and are not part of the study treatment.
What's being tested
- Sex Therapy
Intervention · BEHAVIORAL
Telehealth sex therapy integrating psychoeducation, acceptance and commitment therapy strategies, and sensate focus skills; 10 sessions (~45 minutes) over 6 months delivered by a psychologist.
- Pelvic Floor Physical Therapy
Intervention · BEHAVIORAL
Routine clinical survivorship care including pelvic floor assessment, exercises, behavioral strategies for urinary incontinence, and ongoing therapist-guided rehabilitation.
- Vacuum Erection Device (VED)
Intervention · DEVICE
FDA-cleared manual vacuum pump provided to all participants with education in safe use for penile rehabilitation; not evaluated as an investigational device.
Study details
- Official title
- RESTORE-PC: Rehabilitation and Sex Therapy to Optimize Recovery After Prostate Cancer Treatment: A Randomized Feasibility Trial
- Sponsor
- Duke University
- Conditions
- Prostate Cancer · Urinary Incontinence · Erectile Dysfunction
- Enrolling
- 30 people
- Starts
- 2026-11
- Est. completion
- 2029-11
- Design
- Open-label, randomized, parallel groups
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years and overSex MALEHealthy volunteers Not acceptedYou may qualify if
- Age 18 years or older.
- Biopsy-confirmed localized prostate adenocarcinoma.
- Treated with nerve-sparing radical prostatectomy, radiotherapy, or cryoablation as primary index therapy for prostate cancer at Duke Health.
- Initiating pelvic floor physical therapy as part of routine clinical care.
- Pre-treatment International Index of Erectile Function-5 (IIEF-5) score meeting the eligibility threshold, with or without aids, determined by medical record chart review (when documented within 4 months prior to index treatment) or collected post-treatment with participant recall anchored to the month prior to treatment. Eligibility threshold for the IIEF-5 is at or above 17.
- Able to read and understand English to complete patient-reported outcome measures.
- Ability to provide informed consent.
You can't join if
- Any androgen deprivation therapy (ADT) given for prostate cancer treatment or planned during the intervention or follow-up period, including neoadjuvant, concurrent, or adjuvant ADT.
- Recieved non-nerve-sparing treatment (when applicable).
- Unable to engage in pelvic floor physical therapy or penile rehabilitation protocol.
- Need for additional or secondary prostate cancer treatment during the intervention period.
- Documented cognitive impairment or impairment that would interfere with participation.
- Major psychiatric concern that would interfere with ability to consent or participate, such as schizophrenia, based on the medical record or treating clinician assessment.
- Inability to complete study video visits or questionnaires.
- History of prior local or systemic treatment for prostate cancer
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openDuke University Medical Center
Durham, North Carolina, United States
- Michael W Willis, BA · Contact919-681-8437michael.w.willis@duke.edu
- Smrithi Divakaran, MPH · Contact919-681-7695smrithi.divakaran@duke.edu
- Rebecca A Shelby, PhD · Principal investigator
Recruiting
Study team
Sponsor
Duke University
Study ID Pro00119667
Principal investigator
Rebecca A Shelby, PhD
Duke University
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.